A 2026 UCL study published in BMC Medicine found that around 1.6 million adults in England, Wales, and Scotland used a GLP-1 weight-loss drug in the year to early 2025
Obviously, my body doesnt do it right. Tori Spelling Tori Spelling revealed she used Ozempic and Mounjaro to lose weight after welcoming her sixth child with Dean McDermott
Even among those with payer approval, fewer than one in three prescriptions are ever filled due to patient abandonment, representing an additional 21% demand lost
Arun Sanyal of VCU emphasized, "These initial data show semaglutide slowed MASH progression and reversed existing liver damage
Moisture in the air, combined with warmth, accelerates this reaction
Going forward, well call GLP-1 medications by their drug class name, GLP-1 RA, which is short for glucagon-like peptide-1 receptor agonists